Chimeric Antigen Receptor T Cell Therapy (CAR-T): Genetically programmed immune cell binds to and destroys cancer cell / Therapy is now available for the majority of indications
6. June 2023 • News
6. June 2023 • News
Upcoming viral threats need a fast response to prevent future pandemics. That’s why Leipzig University is now establishing a digital ‘vaccine library’ so that researchers and clinicians can quickly develop effective vaccines in these situations.
Humboldt Prof. Jens Meiler and project manager Dr. Clara T. Schoeder analyze protein structures. Photo: Swen Reichhold
During the 5-year research project, scientists at Leipzig University’s Institute for Drug Development and their partners will be designing virtual vaccine candidates with the aid of classical and AI-supported software. They will be focusing on ten virus families with high pandemic potential. Researchers will be able to generate and seamlessly share knowledge via the library. This can help improve vaccine design – and make their rollout faster in the face of future pandemics. Houston Methodist Hospital in Texas/USA is a partner of the project which is receiving 1.9 million dollars in funding from the global Coalition for Epidemic Preparedness Innovations (CEPI).
Read more at www.uni-leipzig.de
Chimeric Antigen Receptor T Cell Therapy (CAR-T): Genetically programmed immune cell binds to and destroys cancer cell / Therapy is now available for the majority of indications
The Smart Infrastructure Hub Leipzig will receive a further 1,9 million euros from the cluster funding of the Saxon Ministry of Economic Affairs.
A relatively small metropolis in Germany’s Free State of Saxony – a dynamic hub for the life science industry? What was just a vision 20 years ago has become a reality for the city of Leipzig, which from October 24-26 co-hosted BIO-Europe, Europe’s largest annual biotech partnering event.
The European Commission has approved the Saxon ERDF/JTF program for the funding period 2021 to 2027.